Skip to content
Open access

Cancer-Associated Pulmonary Embolism in Contemporary Clinical Practice: Clinical Severity, Incidental Detection, and Early Outcomes in a Real-World Cohort

Aug 2026 · Journal of Clinical Medicine · Vol 15, pp. 6092 · 0 citations · 51 references
Medicine

TL;DR

Acute PE severity appeared to be more closely related to right ventricular involvement than to cancer status, supporting a severity-based rather than cancer-based approach to risk assessment, supporting a severity-based rather than cancer-based approach to risk assessment.

Abstract

Background: The increasing use of routine oncological imaging has led to more frequent detection of incidental pulmonary embolism (PE), potentially modifying the contemporary clinical presentation of cancer-associated pulmonary embolism (CAPE). Methods: We performed a retrospective cohort study including 381 consecutive patients hospitalized with acute PE, of whom 58 had active cancer and 323 had no active malignancy. The primary endpoint was a Severe Hemodynamic Presentation Composite Endpoint (SHPCE), defined as shock, systolic blood pressure < 90 mmHg, and/or high-risk PE according to European Society of Cardiology criteria. Clinical characteristics, severity markers, management strategies, and in-hospital outcomes were compared between patients with CAPE and non-cancer PE (NCPE). Multivariable logistic regression analyses were performed to evaluate factors associated with SHPCE and incidental PE. Results: The patients with CAPE had higher PESI (129.8 ± 29.3 vs. 110.1 ± 32.3; p < 0.001) and sPESI scores (3.03 ± 0.56 vs. 2.68 ± 0.81; p < 0.001), and lower hemoglobin levels (11.7 ± 1.9 vs. 13.2 ± 1.8 g/dL; p < 0.001). Incidental PE was more frequent in CAPE than NCPE cases (13.8% vs. 1.9%; OR 8.45, 95% CI 2.81–25.39; p < 0.001). Despite their higher baseline risk scores, patients with CAPE and NCPE showed similar rates of SHPCE (12.1% vs. 17.6%; p = 0.295), ICU admission (10.3% vs. 11.5%; p = 1.000), and in-hospital mortality (10.3% vs. 11.1%; p = 0.858). In multivariable analyses, right ventricular dysfunction (RVD) showed the strongest association with SHPCE (adjusted OR 10.21, 95% CI 5.34–19.52; p < 0.001), whereas active cancer was not associated with severe presentation. Conclusions: Active cancer was associated with higher clinical risk scores and a greater prevalence of incidental PE but not with increased hemodynamic severity or adverse in-hospital outcomes. Acute PE severity appeared to be more closely related to right ventricular involvement than to cancer status, supporting a severity-based rather than cancer-based approach to risk assessment.

Read PDF

Similar papers

Open access Sep 2026

Clinical features and early warning factors of symptomatic pulmonary embolism after total joint arthroplasty: a retrospective cohort study

Symptomatic pulmonary embolism (PE) is a severe and life-threatening complication following total joint arthroplasty (TJA). Despite advances in diagnosis, treatment, and prediction, postoperative PE still occurs. This study aimed to investigate the onset time window, initial clinical presentations, and preoperative...

Yan-Bin Tian, Yun Zhang, Jin-Guo Ma et al. · 0 citations
Open access Sep 2026

Risk Factors and Outcomes of Postoperative Pulmonary Embolism in Southeast-Asian Patients Undergoing Major Surgery: A Nested Case-Control Study.

INTRODUCTION Postoperative pulmonary embolism (PE) remains a rare but catastrophic perioperative complication. Anesthesia-related factors, perioperative physiological instability, and delayed postoperative mobilization may contribute to its development and associated mortality. However, data on contemporary outcomes in...

Nittaya Boonsri, Patteera Apiwatanakul, Sirawit Sayananon et al. · 0 citations
Review Open access Sep 2026

Acute Pulmonary Embolism: Current Concepts in Risk Stratification and Management

Pulmonary embolism (PE) is a potentially life-threatening manifestation of venous thromboembolism and the third-leading cause of cardiovascular death worldwide. Its clinical presentation is heterogeneous and often nonspecific, contributing to delayed diagnosis and variable outcomes. Diagnosis relies on clinical proba...

Atithi Arora, Y. Gupta, Rosmy Jose et al. · 0 citations
Open access Aug 2026

Characterization of pulmonary embolism events in patients with suspected pneumonia.

Pneumonia and pulmonary embolism (PE) share similar clinical presentations, posing a significant diagnostic challenge. We investigated whether available diagnostic modalities could identify distinct characteristics in patients suspected of pneumonia later diagnosed with PE. Patients who underwent a CT pulmonary angiogr...

A. Kenig, Tal Sigawi, Josef Daniel Shakargy et al. · 0 citations
Open access Sep 2026

Prediction of 30-Day Complicated Clinical Course in Acute Pulmonary Embolism: A Prospective Cohort Comparison of the ESC, Bova, and Modified FAST Models

Background/Objectives: Risk stratification of hemodynamically stable acute pulmonary embolism guides the intensity of monitoring and the site of care, but the available tools use different variables and may classify the same patients differently. We aimed to compare the prognostic performance of three established model...

Melis Efeoğlu Saçak, Emre Kudu · 0 citations
Sep 2026

Central embolic localization in acute pulmonary embolism: Prognostic marker or target for intervention?

BACKGROUND In patients with acute pulmonary embolism (PE), computed tomography pulmonary angiography (CTPA) enables both diagnosis and prognosis. This analysis of symptomatic acute PE patients aims to describe clinical features, management, and short-term outcomes by embolic localization, and to assess the prognostic v...

M. Vedovati, L. Cimini, I. Enea et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.